Korean J Med.  2011 Jun;80(6):664-671.

Clinical Comparison of Drug-Eluting Stents and Bare Metal Stents in Large Coronary Arteries

• Kim WJ
• Cho JH
• Jung JH
• Lee MK
• Yoon JS
• Ahn YS
• Hwang YJ
• Jung HM
• Kim SH
• Kim JY
• Jeong MH

Abstract

BACKGROUND/AIMS
Drug-eluting stents (DES) are superior to bare metal stents (BMS) in reducing restenosis rates across a wide range of patients and lesion subsets.This study compared the clinical outcomes of DES versus BMS in patients with large coronary arteries (> or = 3.5 mm).
METHODS
The study compared 134 patients (59.9 +/- 10.6 years, 90 men, 44 women) who underwent single vessel angioplasty with DESimplantation in large vessels with 115 patients (60.3 +/- 8.9 years, 82 men, 33 women) who received BMS. The clinical outcomes at 12 months were compared between groups. The study end points were major adverse cardiac events (MACE), including cardiac death, nonfatal myocardial infarction, and the need for target vessel and target lesion revascularization.
RESULTS
The baseline clinical coronary angiography and procedural characteristics were similar in both groups. The duration of dual antiplatelet therapy was longer in the DES group than in the BMS group (240 +/- 2.7 vs. 348 +/- 1.7 days, p = 0.042). During the 12-month clinical follow-up, MACE were observed in 13 patients (11.3%) with BMS and 12 patients (9.0%) with DES (p = 0.486).
CONCLUSIONS
For coronary stents implanted in large coronary arteries, DES seems to be more favorable, although no significant differences were observed in the clinical outcomes between DES and BMS during a 1-year clinical follow-up.

Keyword

Coronary diseases; Prognosis; Major cardiac events

MeSH Terms

Angioplasty
Arteries
Coronary Angiography
Coronary Disease
Coronary Vessels
Death
Drug-Eluting Stents
Follow-Up Studies
Glycosaminoglycans
Humans
Male
Myocardial Infarction
Prognosis
Stents
Glycosaminoglycans